Globus Medical stock in focus after recent price moves

Globus Medical (GMED) is back on investor radars after recent trading left the share price around $88.72, with returns mixed over the past month and the past 3 months.

The recent 1 day share price return of 1.29% sits against a softer 30 day share price return of 6.09% and a year to date share price return of 1.63%. The 1 year total shareholder return of 5.27% and 3 year total shareholder return of 47.62% suggest momentum has cooled in the short term compared with the longer record.

If Globus Medical’s recent moves have you looking beyond a single name, this is a good moment to broaden your search with our 27 healthcare AI stocks.

With Globus Medical trading around $88.72, recent returns mixed and some valuation models suggesting a discount, you have to ask yourself: is this a genuine entry point, or is the market already pricing in future growth?

Most Popular Narrative: 16.6% Undervalued

Globus Medical’s widely followed narrative pegs fair value at $106.40 versus the current $88.72, which points to a sizeable gap worth understanding before you judge the setup.

Continued innovation and adoption of robotics, navigation, and minimally invasive procedures, including expansion of the ExcelsiusGPS ecosystem, launch of the Excelsius XR headset, and robust product pipeline, position Globus to capitalize on healthcare digitization trends, driving higher ASPs, stronger market differentiation, and improved gross margins over time.

Want to see what kind of revenue path and profit profile sit behind that $106.40 figure? The narrative leans on specific growth, margin and valuation assumptions that are anything but generic.

Result: Fair Value of $106.40 (UNDERVALUED)

However, there is still real execution risk here if prolonged sales cycles for robotics or ongoing integration issues with NuVasive and Nevro start to drag on growth and margins.

Build Your Own Globus Medical Narrative

If you are not fully on board with this storyline or prefer to test the numbers yourself, you can build a custom view in minutes: Do it your way.

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Globus Medical.

Looking for more investment ideas?

If you stop at one company, you risk missing out on stronger opportunities that better fit your style, return needs and comfort with risk.

• Spot potential value candidates early by scanning 51 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their strengths.
• Prioritise staying power by reviewing solid balance sheet and fundamentals stocks screener (45 results) geared toward companies with stronger financial footing.
• Hunt for off the radar opportunities by checking our screener containing 24 high quality undiscovered gems before they attract broader attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.